Table 1 Schedule of enrolment, interventions and assessments
Study period | |||||||
|---|---|---|---|---|---|---|---|
Recruitment | Baseline | Post-baseline | Source of data collection | ||||
Timepoint | Treatment period | Follow up, 6 months | Follow up, 15 months | ||||
Enrolment | Referral diagnosis, information and informed consent | x | GP | ||||
Assessment of somatic comorbidity | x | GP | |||||
Eligibility interview (including MINI) | x | Interview | |||||
Standardized Assessment of Personality, Abbreviated Scale | x | Interview | |||||
Suicidal ideation | x | Interview | |||||
Interventions | Collaborative care | x | |||||
Treatment as usual | x | ||||||
Assessments | Beck Depression Inventory-II | x | x | x | Self-report | ||
Beck Anxiety Inventory | x | x | x | Self-report | |||
Global Assessment of Functioning | x | x | x | Self-report | |||
Symptom Checklist-90-Revised | x | x | x | Interview | |||
World Health Organization-5 | x | x | x | Self-report | |||
Personal and Social Performance Scale | x | x | x | Interview | |||
Patient-Rated Inventory of Side Effects | x | x | x | Self-report | |||
EuroQol Five-Dimension Questionnaire with Three Levels | x | x | x | Self-report | |||
Sheehan Disability Scale | x | x | x | Self-report | |||
Subscale from Illness Perception Questionnaire Revised scale | x | x | x | Self-report | |||
Chronic Disease Self-efficacy Scales-32 | x | x | x | Self-report | |||
INSPIRE | x | Self-report | |||||
Client Satisfaction Questionnaire-8 + project-specific questions | x | Self-report | |||||
The Diagnostic Apathia Scale | x | x | x | Interview | |||
Sick leave | x | x | x | Register | |||
Medication use | x | x | x | Register | |||
Death | x | x | x | Register | |||
Life-threatening conditions | x | x | x | Register | |||
Outpatient services, admissions and inpatient days | x | x | x | Register | |||
Use of social services | x | x | x | Register | |||
Intervention-specific services and treatment | x | Care managers and psychiatrists | |||||